Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape.

Kermanizadeh A, Powell LG, Stone V, Møller P.

Int J Nanomedicine. 2018 Nov 16;13:7575-7605. doi: 10.2147/IJN.S177418. eCollection 2018. Review.

2.

Nanosize drug delivery system.

Mukherjee B.

Curr Pharm Biotechnol. 2013;14(15):1221.

PMID:
25106648
3.

Nanocarriers for oral drug delivery.

Zhang L, Wang S, Zhang M, Sun J.

J Drug Target. 2013 Jul;21(6):515-27. doi: 10.3109/1061186X.2013.789033. Epub 2013 Apr 26. Review.

PMID:
23621127
4.

Chitosan nanoparticles for oral drug and gene delivery.

Bowman K, Leong KW.

Int J Nanomedicine. 2006;1(2):117-28. Review.

5.

Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.

Moritz M, Geszke-Moritz M.

Adv Clin Exp Med. 2015 Sep-Oct;24(5):749-58. doi: 10.17219/acem/31802.

6.

Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.

Hua S, Marks E, Schneider JJ, Keely S.

Nanomedicine. 2015 Jul;11(5):1117-32. doi: 10.1016/j.nano.2015.02.018. Epub 2015 Mar 14. Review.

7.

Micro- and nanoparticles--medical applications.

Jătariu A, Peptu C, Popa M, Indrei A.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1160-9. Review.

PMID:
20191893
8.

Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.

Galindo-Rodriguez SA, Allemann E, Fessi H, Doelker E.

Crit Rev Ther Drug Carrier Syst. 2005;22(5):419-64. Review.

PMID:
16313233
9.

Disposition of nanoparticle-based delivery system via inner ear administration.

Chen G, Zhang X, Yang F, Mu L.

Curr Drug Metab. 2010 Dec;11(10):886-97. Review.

PMID:
21208174
10.

Oral bioavailability: issues and solutions via nanoformulations.

Pathak K, Raghuvanshi S.

Clin Pharmacokinet. 2015 Apr;54(4):325-57. doi: 10.1007/s40262-015-0242-x. Review.

PMID:
25666353
11.

Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.

Roger E, Lagarce F, Garcion E, Benoit JP.

Nanomedicine (Lond). 2010 Feb;5(2):287-306. doi: 10.2217/nnm.09.110. Review.

PMID:
20148639
12.

Armamentarium of nanoscaled lipid drug delivery systems customized for oral administration: In silico docking patronage, absorption phenomenon, preclinical status, clinical status and future prospects.

Baldi A, Chaudhary M, Sethi S, Abhiav, Chandra R, Madan J.

Colloids Surf B Biointerfaces. 2018 Oct 1;170:637-647. doi: 10.1016/j.colsurfb.2018.06.061. Epub 2018 Jul 2. Review.

PMID:
29986259
13.

Oral fast-release solid dispersion-paradigm shift to nanoparticles.

Wong TW.

Recent Pat Drug Deliv Formul. 2011 Sep;5(3):227-43. Review.

PMID:
21834774
14.

Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.

Nguyen KT, Zhao Y.

Acc Chem Res. 2015 Dec 15;48(12):3016-25. doi: 10.1021/acs.accounts.5b00316. Epub 2015 Nov 25.

PMID:
26605438
15.

Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.

Das S, Chaudhury A.

AAPS PharmSciTech. 2011 Mar;12(1):62-76. doi: 10.1208/s12249-010-9563-0. Epub 2010 Dec 21. Review.

16.

Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.

Hunter AC, Elsom J, Wibroe PP, Moghimi SM.

Nanomedicine. 2012 Sep;8 Suppl 1:S5-20. doi: 10.1016/j.nano.2012.07.005. Epub 2012 Jul 27. Review.

PMID:
22846372
17.

The use of cyclodextrins nanoparticles for oral delivery.

Kanwar JR, Long BM, Kanwar RK.

Curr Med Chem. 2011;18(14):2079-85. Review.

PMID:
21517768
18.

pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.

Liu L, Yao W, Rao Y, Lu X, Gao J.

Drug Deliv. 2017 Nov;24(1):569-581. doi: 10.1080/10717544.2017.1279238. Review.

PMID:
28195032
19.

Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.

Silva AC, Santos D, Ferreira D, Lopes CM.

Curr Med Chem. 2012;19(26):4495-510. Review.

PMID:
22834821
20.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Pérez-Herrero E, Fernández-Medarde A.

Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Review.

Supplemental Content

Support Center